Development of a parallel reaction monitoring-MS method to quantify IGF proteins in dogs and a case of nonislet cell tumor hypoglycemia

Alberto Valdés, Moira Lewitt, Erica Wiss, Margareta Ramström, Emma M. Strage

Research output: Contribution to journalArticle

2 Citations (Scopus)
55 Downloads (Pure)

Abstract

Nonislet-cell tumor hypoglycemia (NICTH) is a rare paraneoplastic phenomenon well described in dogs and humans. Tumors associated with NICTH secrete incompletely processed forms of insulin-like growth factor-II (IGF-II), commonly named big IGF-II. These forms have increased bioavailability and interact with the insulin and IGF-I receptor causing hypoglycemia and growth-promoting effects. Immunoassays designed for human samples have been used to measure canine IGF-I and -II, but they possess some limitations. In addition, there are no validated methods for measurement of big IGF-II in dogs. In the present study, a targeted parallel reaction monitoring MS-based method previously developed for cats has been optimized and applied to simultaneously quantify the serum levels of IGF-I, IGF-II, and IGFBP-3, and for the first time, the levels of big IGF-II in dogs. This method allows the absolute quantification of IGF proteins using a mixture of QPrEST proteins previously designed for humans. The method possesses good linearity and repeatability and has been used to evaluate the IGF-system in a dog with NICTH syndrome. In this dog, the levels of big IGF-II decreased by 80% and the levels of IGF-I and IGFBP-3 increased approximately 20- and 4-times, respectively, after removal of the tumor.
Original languageEnglish
Pages (from-to)18-29
Number of pages12
JournalJournal of Proteome Research
Volume18
Issue number1
DOIs
Publication statusPublished - 30 Oct 2018

Keywords

  • big IGF-II
  • dog NICTH
  • IGF system
  • PRM
  • targeted proteomics

Fingerprint Dive into the research topics of 'Development of a parallel reaction monitoring-MS method to quantify IGF proteins in dogs and a case of nonislet cell tumor hypoglycemia'. Together they form a unique fingerprint.

  • Cite this